PubMed Health⌕ Search

Biomedical subjects

R C Kurtz

Publications and source records attributed to R C Kurtz.

60 records · Page 4Linked to original sources

Risk factors associated with vasovagal reactions during colonoscopy.

To define the syndrome of vasovagal reactions that occur during colonoscopy and to identify those risk factors associated with this development, we prospectively evaluated patients undergoing colonoscopy with monitored sedation. A total of 223 consecutive patients were evaluated during the 60-day study period. A vasovagal reaction was defined as the occurrence of one or more of the following: diaphoresis, sustained bradycardia of less than 60 beats/min or a decrease in heart rate of 10%, or hypotension (systolic blood pressure less than 90 mm Hg, diastolic blood pressure less than 60 mm Hg, or a reduction in blood pressure of more than 10% below a baseline measurement before colonoscopy and after sedation). Thirty-seven (16.5%) of the 223 patients experienced a vasovagal reaction by our criteria. The remaining 186 patients did not; 100 of these patients were randomly selected by computer to form a control group. No statistically significant differences were observed between the vasovagal and control groups with regard to demographics, cardiopulmonary disease, cardiac medications, procedure success, the endoscopist, patient procedure tolerance, colon preparation, or procedure difficulty. A significant difference was seen in the mean dose of midazolam used in the vasovagal group as compared with that used in the control group (4.6 mg versus 3.9 mg, p < 0.04), and moderate to severe diverticulosis was more commonly seen in the vasovagal group as compared with the control group (43% versus 16%, p < 0.02). Thirteen (35%) of the 37 patients who had a vasovagal reaction required medical intervention (5.8% of the 223 patients).(ABSTRACT TRUNCATED AT 250 WORDS)

Bradycardia↗

A randomized trial using videotape to present consent information for colonoscopy.

A randomized controlled trial was conducted to determine if a videotaped presentation by a physician conveys information more effectively than an in-person discussion by the same physician using the identical script. Two hundred one patients undergoing colonoscopy were enrolled in the study. Patients were randomly assigned to one of three groups: video plus discussion, video alone, and discussion alone. A validated, 13-item knowledge test and the State-Trait Anxiety Inventory were administered to all patients. Mean number of correct test answers for video plus discussion was 11.04; for video alone, 10.70; and for discussion alone, 9.61. ANOVA with planned orthogonal comparisons showed that the patients in the two video groups had significantly better scores (p < 0.001) than those in the discussion-only group. No difference was noted between the two video groups (p = 0.32). Anxiety did not increase with increased understanding of the risks and benefits of colonoscopy. This approach may work as well for other invasive medical procedures and could save physician time while laying a foundation for a more personalized discussion.

Adult↗

Particle embolization for hepatocellular carcinoma.

PURPOSE: To evaluate the outcome of all patients undergoing particle embolization for hepatocellular carcinoma at a single institution from January 1, 1993, through December 31, 1995. MATERIALS AND METHODS: The charts and radiographs of all patients undergoing particle embolization during the study period were reviewed. The following information was collected: patient demographics, Child class and Okuda stage, number of embolization treatment sessions, length of hospital stay, complications related to the embolization procedure, including postembolization syndrome, current patient status, and date of death. RESULTS: Forty-six patients underwent 86 embolization sessions during the study period. Postembolization syndrome developed after 70 of the 86 sessions (81%); in four cases (4.6%) this required treatment that extended the patient's hospital stay. Three other complications occurred (3.5%), including a splenic infarct and two episodes of transient hepatic failure, all treated supportively. There was one death within 30 days, but it was not directly attributable to embolotherapy. Follow-up was available for all of the patients who underwent treatment. Thirty-four patients were classified as Child class A, and 12 were classified as Child class B. Thirty patients were classified as Okuda stage I, 14 were classified as Okuda stage II, and two were classified as Okuda stage III. Overall actuarial survival was 50% at 1 year and 33% at 2 years. There was a statistically significant difference in survival between Okuda stage I and stage II patients, but not between Child class A and class B patients. CONCLUSION: Particle embolization for hepatocellular carcinoma is well tolerated and demonstrates actuarial survival of 50% at 1 year and 33% at 2 years.

Carcinoma, Hepatocellular↗

Patient satisfaction with an informed consent process.

PURPOSE: This study evaluates patient and family member level of satisfaction with alternative approaches in obtaining informed consent before colonoscopy or upper gastrointestinal endoscopy. DESCRIPTION: A convenience sample of 204 endoscopy patients at Memorial Sloan-Kettering cancer Center in new York and 102 of their family members were approached to participate in the study. All patients were 19 years of age or older, able to speak and read English, and mentally competent. After proceeding through the informed consent process using both videotape and physician discussion, participants completed a ten-question survey on their previous informed consent experience and their preferences regarding receiving consent information. RESULTS: Overall, participants reported that a combination of videotape and physician explanation was preferred for receiving consent information over either method alone. The participants found that the videotape helped to make the information easier to understand and provided the appropriate amount of information about risks, benefits, and alternatives to the prospective endoscopic procedure. CLINICAL IMPLICATIONS: Patient satisfaction should be a factor in determining the best method of providing informed consent information. Because this study indicates that participants are most satisfied with the method of videotape followed by physician discussion, the addition of the videotape to the informed consent process may be beneficial in preparing the participant for a meaningful dialogue with the physician. The use of the videotape also may eliminate the problem of readability of the written document and ensure that all patients receive the same information. With a concerted effort on the part of oncology healthcare providers, including oncologists, nurses, and patient education professionals, this method may hold promise for ensuring the achievement of informed consent in oncology patients.

Adult↗